1GENE
Hangzhou, Zhejiang, China
About 1GENE
One Gene performs non-invasive cancer screening. With the aim of "letting everyone stay away from cancer earlier," it develops and provides "non-invasive, precise, early-stage, Pratt & Whitney" four advantages of cancer early screening products to help everyone win the battle against cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2022)
- Website: 1gene.com.cn
- Phone: +86 400-163-5588
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/1gene-2489283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.